Tag: PE
Mechanical thrombectomy shifts the needle toward interventional management of PE and...
This advertorial is sponsored by Inari Medical.
Evaluating the current standard of care for the management of acute pulmonary embolism (PE) and deep vein thrombosis...
Jupiter Endovascular announce US FDA approval for SPIRARE II trial
Jupiter Endovascular has announced that the US Food and Drug Administration (FDA) has approved its investigational device exemption (IDE) application for the SPIRARE II US pivotal study. The pivotal trial...
AngioDynamics announces CE mark approval for AlphaVac system
AngioDynamics, a leading medical technology company focused on restoring healthy blood flow in the body’s vascular system, has announced European CE mark approval of...
Penumbra announces FDA clearance of Lightning Flash 2 for the treatment...
Penumbra has announced the US Food and Drug Administration (FDA) clearance and launch of Lightning Flash 2, the next generation computer assisted vacuum thrombectomy (CAVT)...
AngioDynamics receives 510(k) clearance for AlphaVac system in treatment of PE
AngioDynamics, a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and...
Avicenna.AI receives FDA 510k approval for PE and stroke severity technology
Medical imaging artificial intelligence (AI) company Avicenna.AI have today announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA)...
One year on: Matthew Johnson reflects on the PRESERVE trial
“Is more research needed in the world of filters? Yes, but is more research needed to determine whether the class itself is safe? No.”...
Endovascular Engineering announce first patient enrolled in PE thrombectomy trial
Endovascular Engineering, a medical device company involved with clot removal technologies for venous thromboembolism (VTE), has announced the enrolment and treatment of the first...
Computer-assisted vacuum thrombectomy (CAVT) system ‘revolutionises’ pulmonary embolism treatment
This advertorial, sponsored by Penumbra, is intended only for readers outside the USA.
“The advances led by this technology have significantly revolutionised our procedures,” states...
Late breaking STRIKE-PE data shows improved outcomes for pulmonary embolism patients
Penumbra, a global healthcare company focused on innovative therapies, announced the latest STRIKE-PE data evaluating Penumbra’s Indigo aspiration system with Lightning. The results show...
Study provides insights from US cohort of FLASH registry for high-risk...
New research from the FLASH registry shines a light on the effectiveness of large-bore mechanical thrombectomy in managing high-risk pulmonary embolism. The study, titled "Mechanical thrombectomy for high-risk pulmonary embolism:...
“Rapid improvement” in right ventricular metrics following computer-aided mechanical aspiration thrombectomy
Presenting real-world population data in patients with pulmonary embolism (PE), John Moriarty (University of California, Los Angeles Medical Center, Los Angeles, USA) demonstrated results...
Viz.ai to expedite patient enrolment in NIH-funded PE-TRACT clinical trial
Viz.ai has announced it will use its Viz Recruit platform to optimise patient enrolment for the National Institutes of Health (NIH)-funded Pulmonary embolism—thrombus removal...
New study demonstrates IVC filters “safe and effective” in treating venous...
Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep vein blood clots from developing into...
New mechanical thrombectomy systems unlock possibilities for the treatment of venous...
Gerd Grözinger (Tübingen, Germany) chats with Bernhard Gebauer (Berlin, Germany) at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2022 annual meeting (10–14...
Viz.ai launches two new AI-powered modules for pulmonary embolism and aortic...
Viz.ai has announced the US commercial launch of its AI-powered modules for pulmonary embolism and aortic disease. Debuting at VEITHsymposium 2021 (16–20 November, Orlando, USA), the...
Inari Medical announces six-month FLASH registry interim data
Inari Medical has announced positive acute and long-term interim results from the first 500 pulmonary embolism (PE) patients enrolled in the FlowTriever outcomes registry...
AI partnership seeks to boost care coordination and patient triage for...
Viz.ai has partnered with Avicenna.AI in an effort to enable intelligent care coordination and improve patient triage of patients suffering from pulmonary embolism (PE)...
ILLUMENATE four-year pooled analysis has “brought increased clarity” to the paclitaxel...
Sean Lyden (Cleveland, USA), current VIVA Board president, speaks to Vascular News about his two years at the helm, which began with the “controversy on...
Thrombus dissolution with EKOS™ Acoustic Pulse Thrombolysis™ in everyday clinical practice
At the EKOS symposium at LINC 2019, Nils Kucher (Zurich, Switzerland), Houman Jalaie (Aachen, Germany) and Mert Dumantepe (Istanbul, Turkey) share their experiences in...
One-year OPTALYSE PE results reinforce safety and efficacy of shorter, lower...
The study results with the Ekos system (BTG) were presented at the International Society on Endovascular Therapy (ISET; 3–7 February 2018, Florida, USA).
The findings...
ATTRACT trial results to be presented at SIR 2017 meeting
Suresh Vedantham, professor of Radiology and Surgery, Mallinckrodt Institute of Radiology, Washington University School of Medicine in St Louis, USA, is scheduled to present the...
First pulmonary embolism patients in Hong Kong treated with the BTG’s...
The first Hong Kong-based patients diagnosed with pulmonary embolism have been treated using the newly available BTG EKOS system. The EKOS system includes an...
